Canlyniadau Chwilio - Kakkar, A J

  • Dangos 1 - 2 canlyniadau o 2
Mireinio'r Canlyniadau
  1. 1
    A Phase I study of the angiogenesis inhibitor SU5416 (semaxanib) in solid tumours, incorporating dynamic contrast MR pharmacodynamic end points

    A Phase I study of the angiogenesis inhibitor SU5416 (semaxanib) in solid tumours, incorporating dynamic contrast MR pharmacodynamic end points gan O'Donnell, A, Padhani, A, Hayes, C, Kakkar, A J, Leach, M, Trigo, J M, Scurr, M, Raynaud, F, Phillips, S, Aherne, W, Hardcastle, A, Workman, P, Hannah, A, Judson, I

    Cyhoeddwyd 2005
    Cael y testun llawn Cael y testun llawn Cael y testun llawn
    Text
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancer

    Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancer gan Jones, P H, Christodoulos, K, Dobbs, N, Thavasu, P, Balkwill, F, Blann, A D, Caine, G J, Kumar, S, Kakkar, A J, Gompertz, N, Talbot, D C, Ganesan, T S, Harris, A L

    Cyhoeddwyd 2004
    Cael y testun llawn Cael y testun llawn Cael y testun llawn
    Text
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: